Filter News
Area of Research
- (-) Neutron Science (11)
- Biological Systems (1)
- Biology and Environment (48)
- Biology and Soft Matter (1)
- Clean Energy (30)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (1)
- Fusion and Fission (6)
- Fusion Energy (1)
- Isotopes (22)
- Materials (31)
- Materials for Computing (7)
- National Security (9)
- Nuclear Science and Technology (10)
- Supercomputing (50)
News Topics
- (-) Biomedical (9)
- (-) Climate Change (1)
- (-) Frontier (1)
- (-) Polymers (1)
- 3-D Printing/Advanced Manufacturing (6)
- Artificial Intelligence (5)
- Big Data (2)
- Bioenergy (5)
- Biology (5)
- Biotechnology (1)
- Chemical Sciences (1)
- Clean Water (2)
- Composites (1)
- Computer Science (13)
- Coronavirus (8)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (4)
- Environment (6)
- Fossil Energy (1)
- Fusion (1)
- High-Performance Computing (2)
- Machine Learning (3)
- Materials (11)
- Materials Science (20)
- Mathematics (1)
- Microscopy (2)
- Nanotechnology (8)
- National Security (2)
- Neutron Science (73)
- Nuclear Energy (2)
- Physics (8)
- Quantum Computing (1)
- Quantum Science (5)
- Security (2)
- Space Exploration (2)
- Summit (6)
- Sustainable Energy (2)
- Transportation (3)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.